Cognition 2010

Reduced depression and anxiety after 4 weeks of Hericium erinaceus in menopausal women

A randomized double-blind placebo-controlled trial: 30 women (mostly menopausal) were randomized to daily cookies containing 0.5 g of Hericium erinaceus fruiting-body powder (4 cookies/day, 2.0 g/day total) or placebo cookies for 4 weeks. Menopausal symptoms (KMI), depression (CES-D), sleep quality (PSQI) and nonspecific complaints (ICI) were assessed. After the course, the active group showed significant reductions in CES-D and ICI from baseline; on the ICI subscales 'insentive' and 'palpitatio' it significantly beat placebo, with only trends on 'concentration', 'irritating' and 'anxious'. No adverse events.

Nagano M., Shimizu K., Kondo R., Hayashi C., Sato D., Kitagawa K., Ohnuki K. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010;31(4):231–237.

Rationale

The fruiting body of Hericium erinaceus contains hericenones and erinacines — low-molecular-weight compounds that stimulate nerve growth factor (NGF) synthesis — giving grounds to expect effects on central nervous system function and autonomic regulation. This work assessed the clinical effects of 4 weeks of H. erinaceus on menopausal symptoms, depression, sleep quality and nonspecific complaints — states in whose pathogenesis autonomic and neurotrophic imbalance plays a meaningful role.

Methods

A randomized double-blind placebo-controlled trial: 30 women, predominantly in the menopausal period, received cookies with H. erinaceus fruiting-body powder (4 cookies × 0.5 g = 2.0 g/day) or identical placebo cookies for 4 weeks. Scales: Kupperman Menopausal Index (KMI), CES-D depression scale, Pittsburgh Sleep Quality Index (PSQI) and Indefinite Complaints Index (ICI).

Results

After the course, the active group's CES-D and total ICI scores fell significantly from baseline; on the ICI subscales "insentive" and "palpitatio" the active group significantly outperformed placebo, while "concentration," "irritating" and "anxious" showed only trends. No adverse events were recorded.

Conclusions

Four weeks of H. erinaceus intake reduced depression scores and nonspecific complaints in this group — a modest but real signal in a population prone to mood and autonomic symptoms.

Worth noting

The honest framing matters: significant effects appeared on the total ICI and two subscales, not on the headline menopausal or sleep measures — KMI and PSQI did not clearly move. The delivery form (cookies with 2 g of powder) is culinary rather than pharmacological — a strength for real-world relevance and a weakness for standardization. n=30 in a symptom-scale study detects only fairly large effects; the trend-level subscales should not be read as failed proof or proof.